Open company graph database — free web & API
Login

Kyoto University Innovation Capital Co., Ltd.

京都大学イノベーションキャピタル株式会社Kyoto University Innovation Capital Co.,Ltd.Alias
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
0
§01

Basic information

BASIC
Head office
〒606-8317 Kyoto City, Sakyo-ku, Yoshida Honcho 36-1, Kyoto University International Science Innovation Building East Hall 4th FloorSources
Chief executive
Nobuhiro YagiSources
Capital
35,000,000
Employees (non-consolidated)
Employees (consolidated)
Start date
2014-12-22
End date
§02

Websites

1 DOMAINS
§03

Business

7
Investment businessSourcesManagement supportSourcesCollaboration with operating companiesSourcesInternational expansion supportSourcesCompany creationSourcesInvestmentSourcesEntrepreneurship supportSources
§04

Related companies

0 COMPANIES

—

§05

Network

NETWORK
Drag to move · click to open
§07

News

22 ARTICLES

Additional Investment in Sunlit Seedlings Inc.Sources

Kyoto University Innovation Capital (KYOTO-iCAP) has made an additional investment in Sunlit Seedlings, Inc., a Kyoto University spin‑off startup that leverages university research to address challenges in agriculture and the environment.

Kyoto iCAP Makes Additional Investment in Sunlit Seed RingsSources

Kyoto University Innovation Capital Co., Ltd. (Kyoto iCAP) has made an additional investment in Sunlit Seed Rings Co., Ltd., a startup founded at Kyoto University. Sunlit Seed Rings aims to solve challenges in agriculture and environmental sectors by utilizing soil microbes, conducting farmland diagnostics, developing beneficial microbes, and evaluating natural capital.

Kyoto iCAP Completes Sale of Qualips SharesSources

Kyoto University Innovation Capital Co., Ltd. announced that its KYOTO-iCAP Fund No. 1 has sold all shares it held in Qualips, Inc., a startup developing iPS cell‑based treatments for heart disease. The sale was completed on the Tokyo Stock Exchange Growth Market. Qualips recently launched its product "ReHeart" in September 2026.

Completion of the sale of all shares of Qualips Co., Ltd.Sources

The KYOTO-iCAP1 Fund, in which Kyoto iCAP serves as an unlimited partner, sold all shares of Qualips Co., Ltd. that it held on the Tokyo Stock Exchange Growth Market. The fund began investing in the company in July 2018, with a cumulative investment amount of 510 million yen.

Additional Investment in RadioNano TxSources

Kyoto iCAP’s KYOTO-iCAP Fund No. 2 made an additional investment in RadioNano Therapeutics through a third-party allotment of new shares. The investment supports the clinical development of RN-501, a boron-based drug for BNCT.

Kyoto iCAP Adds 200 Million Yen Investment to RadioNano TherapeuticsSources

Kyoto University Innovation Capital Co., Ltd. (Kyoto iCAP) executed a third‑party allotment of new shares in RadioNano Therapeutics Co., Ltd., investing 200 million yen in the first close of the Series B round. The raised funds are earmarked for preparing Phase I/IIa clinical trials of the boron drug RN‑501 for BNCT, as well as for building the manufacturing and supply chain for the investigational product.

Kyoto iCAP Adds Investment to RegCellSources

Kyoto University Innovation Capital Co., Ltd. (Kyoto iCAP) has made an additional investment in RegCell, Inc., a California-based startup that builds on research from Kyoto University. RegCell was founded by Dr. Tomofumi Sakaguchi, a leading immunologist and discoverer of regulatory T cells. The investment supports RegCell’s development of therapies derived from this research.

Kyoto iCAP Makes Additional Investment in RegCellSources

The KYOTO-iCAP Fund No. 2, which has Kyoto University Innovation Capital Co., Ltd. as an unlimited partner, has made an additional investment in RegCell, Inc., a startup founded by Kyoto University. RegCell is developing cell therapies aimed at curing autoimmune diseases based on Professor Shibumi Sakaguchi’s Treg research.

Management Structure Changes AnnouncedSources

Kyoto University Innovation Capital Co., Ltd. announced executive-level personnel changes effective August 8, 2026. Nobuhiro Yagi became President and CEO and Managing Partner, Head of Investment Division I; Ko Kusumi became a Director; and Naoya Kiriyama became Managing Director, General Counsel and Chief Administrative Officer.

Additional Investment in BiPSEE, Inc.Sources

Kyoto-iCAP, acting as general partner of the KYOTO-iCAP Fund II, made an additional investment in BiPSEE. BiPSEE is a medtech startup developing a virtual reality-based digital therapeutic for depression.

§08

Public records

GOV
National Tax Agency basic information5130001054399
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
京都大学イノベーションキャピタル株式会社
Trade name (kana)
キョウトダイガクイノベーションキャピタル
Name in English
Corporation type
301
Address
〒606-8317 京都府京都市左京区吉田本町36番地1
Postal code
6068317
Prefecture code
26
City code
103
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-07-10
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
3924212
METI gBizINFO5130001054399
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5130001054399
Trade name
京都大学イノベーションキャピタル株式会社
Trade name (kana)
キョウトダイガクイノベーションキャピタル
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
京都府京都市左京区吉田本町36番地1
Postal code
6068317
Prefecture
京都府
Prefecture code
26
City or district
京都市左京区
City code
103
Street address
吉田本町36番地1
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2018-07-10
Key information
5130001054399
§09

Sources & updates

SOURCES
↑